Delivery Order SPE2DB20D6036-SPE2DB24FC8GD
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $7,327.60 to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract and there is no set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an indefinite...
- The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,793.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. This delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product, with a performance period ending on February 14, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this contract, which is not...
- The Defense Logistics Agency (DLA) awarded a $17,973.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a potential value of $4,580.32 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to provide this pharmaceutical product to support military treatment programs and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML medication. The contract, valued at $1,161.08, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen Drug Corp and DLA, which serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML medication. The contract has a potential value of $7,475.24 and a performance period through February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order contract is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply OZEMPIC 0.25-0.5MG 1S pharmaceutical products. The contract has a period of performance through March 5, 2024 and a potential value of $1,161.08. This delivery order is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract (IDC) with DLA, which has a potential value...
- The Defense Logistics Agency (DLA) awarded a $3,287.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB20D6036Indefinite Delivery Contract
- SPE2DB20D6036-SPE2DB24FC8GDDelivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,161.08 firm fixed price delivery order contract to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has a performance period through February 2, 2024 and was not set aside for any small business categories. Amerisourcebergen Drug Corp serves as a prime contractor to DLA providing a wide range of pharmaceutical and medical supplies in support of military treatment programs and facilities. This delivery order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver such products and materials to DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/1/24 |